Jesmond Dalli: Ask the Expert: Novel Pro-Resolving Mediators – Agonists in the Resolution of Inflammation – 4
From a series of lectures by Jesmond Dalli, PhD, MHICN presents on the utility of a novel approach using active mediators and levels of special pro resolving mediators to resolve inflammatory conditions.
Clinical use of active mediators for resolution of inflammation has been demonstrated across a variety of chronic conditions and issues, ranging from sepsis to obesity related health conditions, diabetes and vascular diseases to name a view. The special mediators regulate resolution processes. However, they are often deficient in chronic disease states, so nutritional support and availability of these compounds is important for accelerated inflammation resolution.